CETUXIMABΒ
Clinical trials for CETUXIMABΒ explained in plain language.
Never miss a new study
Get alerted when new CETUXIMABΒ trials appear
Sign up with your email to follow new studies for CETUXIMABΒ, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for colorectal cancer: chemo-free combo targets tumors without harsh side effects
Disease control Recruiting nowThis study tests whether a combination of two targeted drugs (cetuximab beta and fruquintinib) with or without immunotherapy can control advanced colorectal cancer without traditional chemotherapy. About 70 adults with a specific genetic type (RAS/BRAF wild-type) will receive the…
Matched conditions: CETUXIMABΒ
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 26, 2026 10:47 UTC
-
New 4-Drug cocktail takes on deadly colorectal cancer
Disease control Recruiting nowThis study tests a combination of four drugs (sintilimab, ipilimumab, cetuximab, and dabrafenib) in people with a specific, hard-to-treat type of colorectal cancer that has spread. The cancer must have a BRAF V600E mutation and be microsatellite stable (MSS). The goal is to see i…
Matched conditions: CETUXIMABΒ
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 19, 2026 12:01 UTC